Increasing Clinical Trial Access for Blood Cancers

Clinical trials are the best instrument to advance treatment for blood cancers, but numerous challenges exist around trial identification, enrollment, and participation. We'll hear perspectives from a community provider and patient advocacy organization on immediate--and forward-thinking--solutions to help this population better access clinical trials, including a tool from the Leukemia and Lymphoma Society to help patients identify cancer clinical trials that may be a fit. Guests:  Ethan Binder, MD Hematologist and OncologistPresbyterian Rust Medical Center Rio Rancho, NM Leah Szumita, MS, RN Director, Clinical Trial Support CenterLeukemia & Lymphoma Society Rye Brook, NY Resources:  ACCC Community Oncology Research Institute  ACORI Call to Action Summit: Activating Equity in Community Oncology Research ASCO-ACCC Joint Research Statement Clinical Trial Support Center (CTSC) Leukemia & Lymphoma Society Research & Clinical Trial Resources at ACCC Ep 60: Advancing Clinical Trial Equity This podcast is the first in a series from the ACCC Community Oncology Research Institute (ACORI).